11. Korisni linkovi

Globalna koalicija za karcinom pluća:

https://www.lungcancercoalition.org/

Karcinom pluća Evropa (LuCE):

https://www.lungcancereurope.eu/

Internacionalna asocijacija za proučavanje karcinoma pluća (IASLC):

www.ioslc.org

Žene protiv karcinoma pluća u Evropi (WALCE):

www.womenogainstlungcancer.eu

Društvo Srbije za borbu protiv raka:

www.serbiancancer.org

American Society of Clinical Oncology (ASCO):

https://www.concer.net/sites/concer.net/files/osco_onswer_immunotheropy.pdf

European Society of Medical Oncology (ESMO):

https://www.esmo.org/Potients/

Reference:

https://medlineplus.gov/ency/article/000821.htm Accessed June 2020.
https://www.sciencenews.org/article/cancer-cells-cast-sweet-spell-immune-system Accessed June 2020.
https://www.cancer.gov/about-cancer/treatment/types Accessed June 2020.
https://www.cancer.gov/about-cancer/treatment/types/chemotherapy Accessed June 2020.
https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/chemotherapy/how-chemotherapy-works Accessed June 2020.
https://www.webmd.eom/cancer/immunotherapy-risks-benefits#1 Accessed June 2020.
https://www.cancer.net/navigating-cancer-care/how-cancer-treated/immunotherapy-and-vaccines/side-effects-immunotherapy Accessed June 2020.
https://www.cancervic.org.au/cancer-information/treatments/treatments-types/immunotherapy Accessed June 2020.
Kwak JJ et al. Radiographics 2015; 35(2):424-437.
https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/immunotherapy/types/monoclonal-antibodies Accessed June 2020.
https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/immunotherapy/types/checkpoint-inhibitors Accessed June 2020.
https://www.cancerresearch.org/immunotherapy/treatment-types/adoptive-t-cell-transfer Accessed: June 2020.
https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/immunotherapy/types/vaccines-to-treat-cancer Accessed June 2020.
https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/immunotherapy/types/vaccines-to-treat-cancer Accessed June 2020.
https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/immunotherapy/types/cytokines Accessed June 2020.
https://www.cancerresearch.org/immunotherapy/treatment-types/oncolytic-virus-immunotherapy Accessed June 2020.
https://immuno-oncologynews.com/oncolytic-virus-therapies/ Accessed June 2020.
Henry NL and Hayes DF. Mol Oncol 2012; 6(2):140-146.
Gosney, JR et al. Biomarkers for immuno-therapy. In: ESMO handbook of immuno-oncology 2018. Pg 43-55. Eds Hannen JBAG et al. ESMO Press.
https://www.cancer.net/navigating-cancer-care/cancer-basics/cancer-care-team/oncology-team Accessed June 2020.
https://www.oncolink.org/cancer-treatment/immunotherapy/all-about-immunotherapy Accessed June 2020.
https://www.uptodate.com/contents/infusion-related-reactions-to-therapeutic-monoclonal-antibodies-used-for-cancer-therapy Accessed June 2020.
https://www.cancer.net/blog/2018-02/what-you-need-know-about-immunotherapy-side-effects Accessed June 2020.
Haanen JBAG et al. Ann Oncol 2017; 28(suppl_4):iv119-iv142.
Brahmer JR et al. J Oncol Pract 2018.14(4)247-249.
National Comprehensive Cancer Network. NCCN clinicaI practice guidelines in oncology (NCCN Cuidelines) in partnership with the American Society of Clinical Oncology (ASCO). Management of immunotheraov-related toxicities. Version 1.2019. November 14 2018.
Brahmer JR et al. J Oncol Pract 2018.14(4)247-249.
National Comprehensive Cancer Netvvork. NCCN clinicaI practice guidelines in oncology (NCCN Guidelines) in partnership vvith the American Society of Clinical Oncology (ASCO). Management of immunotherapy-related toxicities. Version 1.2019. November 14, 2018.
https://www.healthline.com/nutrition/10-benefits-of-exercise Accessed June 2020.
https://www.cancer.net/navigating-cancer-care/how-cancer-treated/chemotherapy/catheters-and-ports-cancer-treatment Accessed: June 2020